AUTL · Autolus Therapeutics plc · Held by Funds
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of AUTL by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 0.64% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.05% | 120,878 |
| Index ETFs | 0.59% | 1,576,263 |
| Active ETFs | 0.00% | 0 |
| Active funds | 0.00% | 0 |
| Unclassified | 0.01% | 22,753 |
| All registered funds | 0.65% | 1,719,894 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding AUTL
13 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| iShares Biotechnology ETF | IBB | 1,428,929 | $2,286,286 | 0.03% | Long | 2026-06-30 | |
| Tema Oncology ETF | CANC | 268,127 | $630,098 | 0.30% | Long | 2026-08-31 | |
| Invesco NASDAQ Future Gen 200 ETF | QQQS | 59,731 | $140,368 | 0.62% | Long | 2026-08-31 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | GWX | 84,409 | $135,054 | 0.02% | Long | 2026-06-30 | |
| PMC Diversified Equity Fund | — | 18,516 | $111,096 | 0.02% | Long | 2024-02-29 | |
| ActivePassive International Equity ETF | APIE | 31,577 | $74,206 | 0.01% | Long | 2026-08-31 | |
| Range Cancer Therapeutics ETF | CNCR | 39,347 | $68,070 | 0.76% | Long | 2025-02-28 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 13,356 | $31,387 | 0.00% | Long | 2026-08-31 | |
| Invesco Nasdaq Biotechnology ETF | IBBQ | 12,421 | $29,189 | 0.03% | Long | 2026-08-31 | |
| ProShares Ultra Nasdaq Biotechnology | BIB | 7,168 | $16,845 | 0.02% | Long | 2026-08-31 | |
| Defiance Nasdaq Junior Biotechnology ETF | — | 1,305 | $8,548 | 0.12% | Long | 2021-09-30 | |
| ProShares UltraPro Nasdaq Biotechnology | — | 610 | $4,990 | 0.02% | Long | 2020-02-29 | |
| Blackstone Alternative Multi-Strategy Fund | — | 14,000 | $22,400 | 0.00% | Short | 2026-06-30 |